首页> 美国卫生研究院文献>Middle East Journal of Digestive Diseases >New Concepts on Reversibility and Targeting of Liver Fibrosis; A Review Article
【2h】

New Concepts on Reversibility and Targeting of Liver Fibrosis; A Review Article

机译:可逆性和靶向肝纤维化的新概念;评论文章

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Currently, liver fibrosis and its complications are regarded as critical health problems. With the studies showing the reversible nature of liver fibrogenesis, scientists have focused on understanding the underlying mechanism of this condition in order to develop new therapeutic strategies. Although hepatic stellate cells are known as the primary cells responsible for liver fibrogenesis, studies have shown contributing roles for other cells, pathways, and molecules in the development of fibrosis depending on the etiology of liver fibrosis. Hence, interventions could be directed in the proper way for each type of liver diseases to better address this complication. There are two main approaches in clinical reversion of liver fibrosis; eliminating the underlying insult and targeting the fibrosis process, which have variable clinical importance in the treatment of this disease. In this review, we present recent concepts in molecular pathways of liver fibrosis reversibility and their clinical implications.
机译:当前,肝纤维化及其并发症被认为是严重的健康问题。随着研究显示出肝纤维化的可逆性,科学家们致力于研究这种疾病的潜在机制,以开发新的治疗策略。尽管已知肝星状细胞是负责肝纤维化的主要细胞,但研究表明,取决于肝纤维化的病因,其他细胞,途径和分子在纤维化发展中也起着重要作用。因此,可以针对每种肝病以正确的方式进行干预,以更好地解决这种并发症。肝纤维化的临床逆转主要有两种方法:消除潜在的侮辱并针对纤维化过程,这在该疾病的治疗中具有重要的临床重要性。在这篇综述中,我们介绍了肝纤维化可逆性分子途径中的最新概念及其临床意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号